Patents by Inventor Jan Horling

Jan Horling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Promoter sequences
    Publication number: 20040191759
    Abstract: The present invention relates an isolated human Site-1 Protease promoter region. The invention also relates to screening methods for agents decreasing the expression of Site-1 protease and thereby being potentially useful for the treatment of medical conditions related to obesity and/or diabetes.
    Type: Application
    Filed: April 20, 2004
    Publication date: September 30, 2004
    Applicant: Biovitrum AB, a Swedish corporation
    Inventors: Lars Abrahmsen, Jonas Ekblom, Margareta Forsgren, Jan Horling, Per Johansson
  • Nucleotide sequences
    Publication number: 20020172988
    Abstract: The present invention relates to human metalloprotease M8 polypeptides and to nucleic acid molecules coding for such polypeptides. The invention further relates to vectors and cells comprising the nucleic acid molecules, as well as to methods for screening for test compounds which affect the insulin-signaling pathway.
    Type: Application
    Filed: May 15, 2002
    Publication date: November 21, 2002
    Inventors: Jan Horling, Magnus Jansson, Eva Danielsson, Per Johansson, Staffan Lake, Joakim Nilsson
  • Promoter sequences
    Publication number: 20020082404
    Abstract: The present invention relates an isolated human Site-1 Protease promoter region. The invention also relates to screening methods for agents decreasing the expression of Site-1 protease and thereby being potentially useful for the treatment of medical conditions related to obesity and/or diabetes.
    Type: Application
    Filed: June 26, 2001
    Publication date: June 27, 2002
    Inventors: Lars Abrahmsen, Jonas Ekblom, Margareta Forsgren, Jan Horling, Per Johansson